TCT 698: Impact of Optical Coherence Tomography-Guided Percutaneous Coronary Intervention for the Complex Lesions According to Lesion Length and Vessel Diameter: Results from the OCCUPI Randomized Trial
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation; Amgen</li><li>Grant Support/Research Contract - Medtronic; Merit Medical Systems</li></ul>